THE EPOXIDES, ethylene oxide and propylene oxide are used extensively for fumigation of stored agricultural products. Ethylene oxide, because of its effective bactericidal properties, is used for the sterilization of surgical equipment which is heat labile. Therefore, exposure of human beings can occur in various ways. As various monofunctional epoxides show an oncogenic activity in animal tests (Druckrey et al., 1970; Van Duuren et al., 1963; 1966; 1967) , a corresponding effect was also expected with ethylene oxide and propylene oxide. Walpole (1958) has demonstrated the carcinogenicity ofpropylene oxide by s.c. injection into rats. In the case of ethylene oxide, however, no such effect has yet been determined. Reyniers et al. (1964) (Pott et al., 1973) . The compounds, ethylene oxide (J. T. Baker Chemicals B.V., Deventer, Holland) and propylene oxide (MerckSchuchardt, Muinchen, Germany) were tested for impurities using the following methods: infrared spectra, capillary column gas chromatography and fluorescence spectra. 100 female NMRI-mice were used per compound and dosage.
The solvent was tricaprylin (Roth, Karlsruhe, Germany) cooled to 0°C. Treatments were given by s.c. injection once weekly in the interscapular area using sterile tuberculin syringes and needles. Ethylene oxide was administered in a weekly dosage of 1P0 mg, 0 3 mg and 0-1 mg/animal, propylene oxide in a weekly dosage of 2-5 mg, 1P0 mg, 0 3 mg and 041 mg/animal. These quantities of the compounds were contained in 0-1 ml tricaprylin. For control purposes one group was treated with tricaprylin only and one group received no treatment. Up to now the animals have been treated for 91 weeks.
At present between 25% and 45% of the animals used are still living in the various test groups. The preliminary results of the study are shown in the Table. The Table shows 88t Neff: effective animal number: animals which were alive when the first animal died with tumour at the injection site (for ethylene oxide after 50 weeks, for propylene oxide after 39 weeks). Na: total number dead up to 91st week.
Nb: animals dead with tumour at the injection site. Nc: animals dead with tumour at sites distant from the injection area. * number of animals alive after 39 weeks. t number of animals alive after 50 weeks.
the injection site were sarcomas. After ethylene oxide, the first tumour appeared in the 50th week, and after propylene oxide in the 39th week. At the highest dosages, 12 local tumours have occurred with ethylene oxide and 15 with propylene oxide. The Table also shows that, with an increase of the total applied dosage the number of subcutaneous tumours at the injection site also increases. With low dosages of propylene oxide, however, this effect is no longer clear. At a total dosage of 91-0 mg/animal the effect of ethylene oxide corresponds to that of propylene oxide. In the case of lower dosages ethylene oxide seems to be more effective than propylene oxide.
The number of tumours at sites distant from the injection area is not significantly greater in the groups treated with ethylene oxide and propylene oxide than in the controls. Previous evaluation has shown that these tumours consist mainly of lymphomas, both for treated and control groups. At the end of this study, when all results are available, the histological results will be reported in detail. Our results show that s.c. injections of mice once a week with ethylene oxide and propylene oxide produced tumours at the injection site, the yield corresponding to dosage.
